Trademark: 90600678
Word

Status
Dead
Status Code
606
Status Date
Monday, September 18, 2023
Serial Number
90600678
Mark Type
2000
Filing Date
Wednesday, March 24, 2021
Published for Opposition
Tuesday, June 21, 2022
Abandoned Date
Monday, September 18, 2023

Trademark Owner History
LivePerson, Inc. - Owner At Publication

Classifications
9 Downloadable computer application software for mobile phones, namely, software for covid-19 and other infectious disease identification; Downloadable computer application software for computers, namely, software for covid-19 and other infectious disease identification; Downloadable mobile applications for health screenings relating to COVID-19 and other infectious disease; Downloadable mobile applications for tracking and reporting health conditions and symptoms; Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical research, medical laboratory, research, and scientific purposes and parts and fittings thereof; Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical research, medical laboratory, research, and scientific purposes related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical research, medical laboratory, research, and scientific purposes, namely, for COVID-19 and other infectious diseases
5 Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19 and other infectious diseases; Respiratory rapid tests, namely, medical diagnostic assays for use in performing respiratory rapid tests related to COVID-19 and other infectious diseases; Medical diagnostic kits comprised of reagents and assays for use in disease detection, screening, treating and monitoring, including, monitoring COVID-19 and other infectious diseases and also including swabs, including nasal and throat swabs, and medical sample tubes; COVID-19 rapid tests comprising medical diagnostic reagents and assays for withdrawing and testing respiratory droplets and also including parts and fittings thereof
35 Appointment scheduling services for mobile healthcare patients in the field of Covid-19 and other infectious diseases
45 Online personal concierge services for others comprising making requested personal arrangements and reservations and providing customer-specific information to meet individual needs; Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying physical sites visited by persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments; Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying contacts of persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments
44 Healthcare services, namely, treatment of patients for infectious diseases or medical disorders; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a web site featuring medical information; Health care services, namely, disease management programs; Telehealth services, namely, providing telemedicine and services in conjunction with providing medical and healthcare services; Mobile healthcare services in the field of Covid-19 and other infectious disease testing, health assessments, intravenous infusion therapy; Medical diagnostic testing for Covid-19 and other infectious diseases
10 Medical instruments, namely, biosensors for detecting Covid-19 and other infectious diseases in a patient; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for medical diagnostic purposes, namely, for COVID-19 and other infectious diseases
42 Software as a service (SAAS) services featuring software for enabling consumers to access and manage their bank accounts, manage their debit and credit cards and usage, conduct bank transactions, seek investment advice, complete banking related intents and actions, provide data regarding preferences to customize their experience with the application and receive promotions from their bank regarding their preferences and to provide a concierge service to consumers; Software as a service (SAAS) services featuring software for enabling a personalized banking experience, namely, concierge and banking services to consumers about customized products and services based on consumer preferences and data that consumers share; Software as a service (SAAS) services featuring software for web-based access to applications and services; Software as a service (SAAS) services featuring software for using artificial intelligence, text recognition and natural language understanding for communicating with online banking customers; Software as a service (SAAS) services featuring software for providing interactive message services for customers; Software as a service (SAAS) services featuring software for facilitating interaction, connections, and conversations between users in the digital engagement, conversational commerce, messaging, artificial intelligence, bots and automation, and customer engagement; Software as a service (SAAS) services featuring software for online social networking; Software as a service (SAAS) services featuring software for concierge service in the nature of providing personalized and customized communications, customer support, and features and offers based on consumer preferences and data collected from the user; Providing temporary use of on-line non-downloadable authentication software for controlling access to and communications with computers and computer networks; Software as a Service (SaaS) services featuring software for processing electronic payments to and from others; Software as a Service (SaaS) services featuring software for authentication; Software as a Service (SaaS) services featuring software for processing mobile payments; Software as a Service (SaaS) services featuring software for use in contactless transactions with retailers, merchants, and vendors via mobile devices used to process mobile payments; Software as a Service (SaaS) services featuring software for transmitting, processing, facilitating, verifying, and authenticating credit and debit card information and transaction and payment information; Software as a Service (SaaS) services featuring software for ensuring the security of mobile payments, of contactless transactions with retailers, merchants and vendors via mobile devices, and of credit and debit card information; Software as a Service (SaaS) services featuring software for the storage, transmission, verification, and authentication of credit and debit card and other payment and transaction information; Software as a service (SAAS) services featuring software for web-based access to applications and services for managing bank accounts, managing debit and credit cards and usage, conducting bank transactions, and seeking banking and investment advice; Software as a service (SAAS) services featuring software for enabling a personalized banking experience with respect to managing bank accounts, managing debit and credit cards and usage, conducting bank transactions, and seeking banking and investment advice; Providing temporary use of online non-downloadable software for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; Providing temporary use of online non-downloadable software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Providing temporary use of web-based software applications for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Software as a service (SAAS) services featuring software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms
The mark consists of the outline of a heart with a break on the bottom right side of the heart.

Trademark Events
Sep 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 18, 2023
Abandonment - No Use Statement Filed
Apr 19, 2023
Teas Change Of Correspondence Received
Apr 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2023
Sou Extension 1 Granted
Feb 16, 2023
Sou Extension 1 Filed
Feb 16, 2023
Sou Teas Extension Received
Nov 16, 2022
Assigned To Examiner
Aug 16, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 21, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2022
Published For Opposition
Jun 1, 2022
Notification Of Notice Of Publication E-Mailed
May 14, 2022
Approved For Pub - Principal Register
May 13, 2022
Teas/Email Correspondence Entered
May 13, 2022
Correspondence Received In Law Office
May 13, 2022
Teas Response To Office Action Received
Apr 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 8, 2022
Teas Change Of Correspondence Received
Apr 8, 2022
Teas Change Of Owner Address Received
Nov 16, 2021
Notification Of Non-Final Action E-Mailed
Nov 16, 2021
Non-Final Action E-Mailed
Nov 16, 2021
Non-Final Action Written
Nov 10, 2021
Assigned To Examiner
Jun 30, 2021
Notice Of Design Search Code E-Mailed
Jun 29, 2021
New Application Office Supplied Data Entered
Mar 27, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24